Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CPA1 | P15085 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21258133 | 0.82 | CPA1 (0.44) | ALDH1A1CYP2C19LMNACPA1 | |
| SCHEMBL19204850 | 0.77 | ALDH1A1 (0.42) | ALDH1A1CYP2C19LMNACPA1SMN1; SMN2 | |
| SCHEMBL28293955 | 0.77 | ALDH1A1 (0.42) | ALDH1A1CYP2C19LMNACPA1SMN1; SMN2 | |
| SCHEMBL7556173 | 0.77 | CPA1 (0.42) | ALDH1A1CYP2C19LMNACPA1SMN1; SMN2 | |
| SCHEMBL19204849 | 0.77 | ALDH1A1 (0.42) | ALDH1A1CYP2C19LMNACPA1SMN1; SMN2 | |
| SCHEMBL27401781 | 0.75 | ALDH1A1 (0.41) | ALDH1A1CYP2C19LMNACPA1SMN1; SMN2 | |
| SCHEMBL26640113 | 0.73 | ALDH1A1 (0.40) | ALDH1A1CYP2C19LMNACPA1SMN1; SMN2 | |
| SCHEMBL7563800 | 0.73 | CA1 (0.50) | ALDH1A1CYP2C19LMNACPA1 | |
| SCHEMBL27546330 | 0.73 | — | — | |
| SCHEMBL5965786 | 0.72 | ZDHHC7 (0.65) | ALDH1A1ZDHHC7SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017133657-A1 | PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATMENT, AMELIORATION OR PREVENTION OF INFLUENZA | SAVIRA PHARMACEUTICALS GMBH (AT) | 2017-08-10 | — | — | WO | disclosed |
| WO-2017133670-A1 | PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATMENT, AMELIORATION OR PREVENTION OF INFLUENZA | SAVIRA PHARMACEUTICALS GMBH (AT) | 2017-08-10 | — | — | WO | disclosed |
| WO-2017133657-A1 | PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATMENT, AMELIORATION OR PREVENTION OF INFLUENZA | SAVIRA PHARMACEUTICALS GMBH (AT) | 2017-08-10 | — | — | WO | disclosed |